Effects of β2-Agonists and Budesonide on Interleukin-1β and Leukotriene B4Secretion: Studies of Human Monocytes and Alveolar Macrophages
Authors:
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Journal of Asthma
- Vol. 35 (7) , 565-573
Abstract
The aims of the present study were to determine whether β2-agonists (short-and long-acting) and a glucocorticoid (budesonide) influence the secretion of a pro-inflammatory cytokine (interleukin-1, [IL-1]) and a granulocyte attractant (leukotriene B4 [LTB4]) and to compare these effects on blood monocyte and alveolar macrophages. Alveolar macrophages (obtained by bronchoalveolar lavage) and blood monocytes from 26 healthy nonsmokers were stimulated with lipopolysaccharide or human serum opsonized zymosan. The influence of four β2-agonists (salbutamol, terbutaline, formoterol, and salmeterol) and a corticosteroid (budesonide) on the release of interleukin-1β (IL-1β) and LTB4 was studied in a dose-response manner (10-−8-10-−5 mol/L for β2-agonists and 10-−10-10-−6mol/L for budesonide). The stimulated IL-1β secretion was significantly greater in blood monocytes than in alveolar macrophages (p < 0.05), but alveolar macrophages were much more capable of secreting LTB4 than were blood monocytes (p < 0.001). Budesonide significantly inhibited the release of IL-1β from blood monocytes (p < 0.001), but no such effect was observed in alveolar macrophages. Budesonide did not influence the release of LTB4 in either cell type. The β2-agonists neither influenced the LTB4 nor the IL-β secretion in either cell type with the exception of formoterol, which stimulated IL-1β secretion at the highest concentration (10-−5mol/L, p < 0.05). In conclusion, β2-agonists exhibited only minor effects on IL-1β secretion from blood monocytes and no effect on LTB4-secretion from either cell type, and budesonide effectively inhibited the IL-1β release in blood monocytes, but not in alveolar macrophages. Thus, induced secretion of LTB4 and IL-1β, and the sensitivity to corticosteroids with regard to IL-1β secretion, change during the transformation from blood monocytes to alveolar macrophages.Keywords
This publication has 28 references indexed in Scilit:
- Characterization of phospholipase A2 activity in rat RPAR-induced pleurisyInflammation Research, 1991
- β2-agonists in asthmaThe Lancet, 1991
- Protection against allergen-induced asthma by salmeterolThe Lancet, 1990
- Inhibition of anti‐IgE induced skin responsein normals by formoterol, a new β2‐adrenoceptor agonist, and terbutalineAllergy, 1990
- Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseasesJournal of Allergy and Clinical Immunology, 1989
- Leukotriene B4 as a mediator of early and late reactions to antigen in humans: The effect of systemic glucocorticoid treatment in vivoJournal of Allergy and Clinical Immunology, 1989
- Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.Journal of Clinical Investigation, 1985
- Activation of neutrophils and monocytes after allergen- and histamine-induced bronchoconstrictionJournal of Allergy and Clinical Immunology, 1985
- Interaction of glucocorticoids with macrophages. Identification of glucocorticoid receptors in monocytes and macrophages.Journal of Experimental Medicine, 1978
- Inhibition by Sympathomimetic Amines of Histamine Release induced by Antigen in Passively Sensitized Human LungNature, 1969